Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Jul 1;210(1):159-60.
doi: 10.1093/infdis/jiu027. Epub 2014 Jan 12.

Reply to Karch et al

Hiroyu Hatano, Peter Bacchetti, Priscilla Y Hsue, Steven G Deeks
Comment

Reply to Karch et al

Hiroyu Hatano et al. J Infect Dis. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Karch A, Krumkamp R, Kreuels B. Randomized, placebo-controlled trial or post hoc subgroup analysis: the importance of standardized and comprehensive reporting. J Infect Dis. 2014;210:158–9. - PubMed
    1. Hatano H, Strain MC, Scherzer R, et al. Increase in 2-LTR circles and decrease in D-dimer after raltegravir intensification in treated HIV-infected patients: a randomized, placebo-controlled trial. J Infect Dis. 2013;208:1436–42. - PMC - PubMed
    1. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203. - PMC - PubMed
    1. Buzon MJ, Massanella M, Llibre JM, et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med. 2010;16:460–5. - PubMed
    1. Hatano H, Hayes TL, Dahl V, et al. A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis. 2011;203:960–8. - PMC - PubMed

Publication types

MeSH terms

Substances